Tag: Vaccines
For Dialysis Recipients, Antibody Response Lowest With Ad26.COV2.S
Patients receiving attenuated adenovirus vaccine more likely to have no seroconversion, no detectable or diminished IgG response
Cell Culture-Derived Influenza Vaccine Efficacious in Children
Vaccine efficacy consistent in subgroups according to age, sex, race, and previous influenza vaccination
Immunocompromised May Need Fourth COVID-19 Shot: CDC
Small studies have shown that fully vaccinated immunocompromised people account for ~44 percent of breakthrough cases leading to hospitalization
Non-COVID-19 Mortality Not Increased After COVID-19 Vaccination
Adjusted relative risks reduced for non-COVID-19 mortality after receipt of Pfizer-BioNTech, Moderna, Janssen vaccines
FDA Advisors Approve Emergency Use of Pfizer Vaccine in Children 5 to 11
Vote was nearly unanimous at 17 to 0, with one abstention; FDA expected to make a final ruling in a matter of days
Biden Admin Offers Details of Vaccination Requirements for Foreign Travelers
New policy comes as the Biden administration eases restrictions that ban nonessential travel from several dozen countries
Moderna Says Its COVID-19 Vaccine Works Well in Children Aged 6 to 11
Trial included more than 4,700 children who received two shots of the vaccine 28 days apart
BNT162b2 Highly Effective Against Delta Variant in Teens
At seven to 21 days after second dose, estimated effectiveness was 90 percent against infection, 93 percent against symptomatic COVID-19
mRNA Vaccine More Effective Booster to ChAdOx1 nCoV-19
Heterologous ChAdOx1 nCoV-19/mRNA prime-boost vaccination more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19
